4//SEC Filing
Roberts Christopher D. 4
Accession 0000899243-20-034189
CIK 0001701541other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 7:42 PM ET
Size
7.1 KB
Accession
0000899243-20-034189
Insider Transaction Report
Form 4
Roberts Christopher D.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-15−3,200→ 176,109 totalExercise: $10.86Exp: 2029-09-08→ Common Stock (3,200 underlying) - Exercise/Conversion
Common Stock
2020-12-15$10.86/sh+3,200$34,752→ 3,200 total
Footnotes (1)
- [F1]25% of the shares subject to this option vested and became exercisable on September 3, 2020, with the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001788368
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 7:42 PM ET
- Size
- 7.1 KB